[1]
Quiroga, J.; Hernandez, P.; Insuassty, B.R.; Abonia, R.; Cobo, J.; Sanchez, A.; Nogueras, M.; Low, J.N. Control of the reaction between 2-aminobenzothiazoles and Mannich bases. Synthesis of pyrido[2,1-b][1,3]benzothiazoles versus [1,3]benzothiazolo[2,3-b]quinazolines. J. Chem. Soc., Perkin Trans., 2002, 1, 555-559.
[2]
Hutchinson, I.; Jennings, S.A.; Vishnuvajjala, B.R.; Westwell, A.D.; Stevens, M.F.G. Antitumor benzothiazoles. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl) benzothiazole amino acid prodrugs. J. Med. Chem., 2002, 45, 744-747.
[3]
Hargrave, K.D.; Hess, F.K.; Oliver, J.T. N-(4-Substituted-thiazolyl) oxamic acid derivatives, new series of potent, orally active anti- allergy agents. J. Med. Chem., 1983, 26, 1158-1163.
[4]
Patt, W.C.; Hamilton, H.W.; Taylor, M.D.; Ryan, M.J.; Taylor, D.G.; Connolly, C.J.C.; Doherty, A.M.; Klutchko, S.R. Sircar, Steinbaugh, B.A.; Batley, B.L.; Painchaud, C.A.; Rapundalo, S.T.; Michniewicz, B.M.; Olson, S.C. Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors. J.of Med. Chem., 1992, 35, 2562-2572.
[5]
Shivarama, H.B.; Malini, K.V.; Rao, B.S.; Sarojini, B.K.; Suchetha, K.N. Synthesis of some new 2,4-disubstituted thiazoles as possible antibacterial and anti-inflammatory agents. Eur. J. Med. Chem., 2003, 38, 313-318.
[6]
Jaen, J.C.; Wise, L.D.; Caprathe, B.W.; Tecle, B.W.; Bergmeier, S.; Humblet, C.C.; Heffner, T.G.; Meltzner, L.T.; Pugsley, T.A. 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: A novel class of compounds with central dopamine agonist properties. J. Med. Chem., 1990, 33, 311-317.
[7]
Tsuji, K.; Ishikawa, H. Synthesis and anti-pseudomonal activity of new 2-isocephems with a dihydroxypyridone moiety at C-7. Bioorg. Med. Chem. Lett., 1994, 4, 1601-1606.
[8]
Vicini, P.; Geronokaki, A.; Incerti, M.; Busonera, B. Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases. Bioorg. Med. Chem., 2003, 11, 4785-4789.
[9]
Fathalla, W. Syntheses and reactions of methyl[3-(4-phenyl-thiazol-2-yl)-thioureido] alkanoates and related compounds. ARKIVOC, 2008, 12, 245-255.
[10]
Bell, F.W.; Cantrell, A.S.; Hogberg, M.; Jaskunas, S.R.; Johansson, N.G.; Jordon, C.L.; Kinnick, M.D.; Lind, P.; Morin, J.M.; Noreen, R.; Oberg, B.; Palkowitz, J.A.; Parrish, C.A.; Pranc, P.; Sahlberg, C.; Ternansky, R.J.; Vasileff, R.T.; Vrang, L.; West, S.J.; Zhang, H.; Zhou, X.X. Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. synthesis and basic structure-activity relationship studies of PETT analogs. J. Med. Chem., 1995, 38, 4929-4936.
[11]
Ergenc, N.; Capan, G.; Gunay, N.S.; Ozkirimli, S.; Gungor, M.; Ozbey, S.; Kendi, E. Synthesis and hypnotic activity of new 4-thiazolidinone and 2-thioxo-4,5-imidazolidinedione derivatives. Arch. Pharm. Pharm. Med. Chem., 1999, 332, 343-347.
[12]
Carter, J.S.; Kramer, S.; Talley, J.J.; Xpenning, J.J.; Collins, P.; Graneto, M.J.; Seibert, K.; Koboldt, C.; Masferrer, J.; Zweifel, B. Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. Lett., 1999, 9, 1171-1174.
[13]
Badorc, A.; Bordes, M.F.; De Cointet, P.; Savi, P.; Bernat, A.; Lale, A.; Petitou, M.; Maffrand, J.P.; Herbert, J.M. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: Identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl] phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]piperid-4-yl]amino] propionate (SR 121787) as a potent and long-acting antithrombotic agent. J. Med. Chem., 1997, 40, 3393-3401.
[14]
Rudolph, J.; Theis, H.; Hanke, R.; Endermann, R.; Johannsen, L.; Geschke, F.U. seco-Cyclothialidines: New concise synthesis, inhibitory activity toward bacterial and human dna topoisomerases, and antibacterial properties. J. Med. Chem., 2001, 44, 619-626.
[15]
Bonila, P.M.; Cardena, A.P.; Tellez, J.L.A.; Rejon, G.J.M. Preparation, antimicrobial activity, and toxicity of 2-amino-4-arylthiazole derivatives. Heteroatom Chem., 2006, 17, 254-260.
[16]
Parmar, K.A.; Suthar, B.G.; Prajapati, S. Synthesis and antibacterial evaluation of some novel 2-arylamino-4-phenyl-thiazolyl derivatives. Bull. Korean Chem. Soc., 2010, 31, 793-797.
[17]
Prajapati, A.K.; Modi, V.P. Synthesis and biological evaluation of some substituted amino thiazole derivatives. J. Chil. Chem. Soc., 2010, 55, 240-243.
[18]
Desai, N.C.; Bhatt, N.B.; Somani, H.C.; Trivedi, A.R. Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles. Eur. J. Med. Chem., 2013, 67, 54-59.
[19]
Idhayadhulla, A.; Kumar, R.S.; Nasser, A.J.A. Synthesis, characterization and antimicrobial activity of new pyrrole derivatives. J. Mexican . Chem. Soc., 2011, 55, 218-223.
[20]
Satoh, A.; Nagatomi, Y.; Hirata, Y.; Ito, S.; Suzuki, G.; Kimura, T.; Maehara, S.; Hikichi, H.; Satow, A.; Hata, M.; Ohta, H.; Kawamoto, H. Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist. Bioorg. Med. Chem., 2009, 19, 5464-5468.
[21]
Akbari, J.D.; Mehta, K.B.; Pathak, S.J.; Joshi, H.S. Synthesis and antimicrobial activity of some new pyrazolo[3,4-d]pyrimidines and thiazolo[4,5-d]pyrimidines. Ind J. Chem., 2008, 47B, 477-480.
[22]
Akbari, J.D.; Kachhadia, P.K.; Tala, S.D.; Bapodra, A.H.; Dhaduk, M.F.; Mehta, K.B.; Pathak, S.J.; Joshi, H.S. Synthesis of some new pyrazolo[3,4-d]pyrimidines and thiazolo [4,5-d]pyrimidines and evaluation of their antimicrobial activities. Phosphrus Sulfur Silicon Rel. Elem., 2008, 183, 1471-1477.
[23]
Sanfilippo, P.J.; Jetter, M.C.; Cordova, R.; Noe, R.A. Novel thiazole based heterocycles as inhibitors of LFA-1/ICAM-1 mediated cell adhesion. J. Med. Chem., 1995, 38, 1057-1059.
[24]
Saravanan, G.; Alagarsamy, V.; Prakash, C.R. Synthesis of novel thiazole derivatives as analgesic agents. Asian J. Res. Pharm. Sci., 2011, 1, 134-138.
[25]
Siddiqui, N.; Ashan, W. Triazole incorporated thiazoles as a new class of anticonvulsants: Design, synthesis and in vivo screening. Eur. J. Med. Chem., 2010, 45, 1536-1543.
[26]
Gupta, V.; Kant, V. A review on biological activity of imidazole and thiazole moieties and their derivatives. Sci. International., 2013, 1, 253-260.
[27]
Geronikaki, A.; Litina, D.H.; Chatziopoulos, C.; Soloupis, G. Synthesis and biological evaluation of new 4,5-disubstituted-thiazolyl amides, derivatives of 4-hydroxy-piperidine or of 4-N-methyl piperazine. Molecules, 2003, 8, 472-479.
[28]
Mokale, S.N.; Sanap, P.T.; Shinde, D.B. Synthesis and hypolipidemic activity of novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy) acetic acid derivatives. Eur. J. Med. Chem., 2010, 45, 3096-3100.
[29]
Bhattacharya, P.; Leonard, J.T.; Roy, K. Exploring QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists using FA and GFA techniques. Bioorg. Med. Chem., 2005, 13, 1159-1165.
[30]
Scheiff, A.B.; Yerande, S.G.; El Tayeb, A. 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists. Bioorg. Med. Chem., 2010, 18, 2195-2203.
[31]
Sperry, J.B.; Wright, D.L. Furans, thiophenes and related heterocycles in drug discovery. Curr. Opin. Drug Discovery Dev., 2005, 8, 723-740.
[32]
Breslow, R. On the mechanism of thiamine action. IV.1 evidence from studies on model systems. J. Am. Chem. Soc., 1958, 80, 3719-3726.
[33]
Fosbinder, W. Sulfanilamido derivatives of heterocyclic amines. J. Am. Chem. Soc., 1939, 61, 2032-2033.
[34]
Tsuruoka, A.; Kaku, Y.Y.; Kakinumato, H.; Tsukada, I.; Yanagishawa, M.; Naito, T. Synthesis and antifungal activity of novel thiazole-containing triazole antifungals. J. Chem. Pharm. Bull., 1997, 45, 1169-1176.
[35]
Schwarz, G. 2,4-Dimethylthiazole. Org. Synth., 1945, 3, 332-333.
[36]
Alajarín, M.; Cabrera, J.; Pastor, A.; Sanchez-Andrada, P.; Bautista, D. On the [2+2] cycloaddition of 2-aminothiazoles and dimethyl acetylenedicarboxylate, experimental and computational evidence of a thermal disrotatory ring opening of fused cyclobutenes. J. Org. Chem., 2006, 71, 5328-5339.
[37]
Sheldrake, P.W.; Matteucci, Mc. D.M.E. Facile generation of a library of 5-aryl-2-arylsulfonyl-1,3-thiazoles. Synlett, 2006, 3, 460-462.
[38]
Potewar, T.M.; Ingale, S.A.; Kumar, V.S. Efficient synthesis of 2,4-disubstituted thiazoles using ionic liquid under ambient conditions: a practical approach towards the synthesis of Fanetizole. Tetrahedron, 2007, 63, 11066-11069.
[39]
Karade, H.; Sathe, M.; Kaushik, M.P. An efficient method for the synthesis of 2-aminothiazoles using silica chloride as a heterogeneous catalyst. Catal. Commun., 2007, 8, 741-746.
[40]
Narender, M.; Reddy, S.M.; Sridhar, R.; Nageswar, Y.V. Aqueous phase synthesis of thiazoles and aminothiazoles in the presence of β-cyclodextrin. Tetrahedron Lett., 2005, 46, 5953-5955.
[41]
Das, B.; Reddy, S.V.; Ramu, R. A rapid and high-yielding synthesis of thiazoles and aminothiazoles using ammonium-12-molybdophosphate. J. Mol. Catal. A. Chem., 2006, 252, 235-237.
[42]
Amrita, A.; Senthilkumar, G.P. Synthesis and biological evaluation of some new substituted thiazole analogues. Der Pharma Chemica., 2011, 3, 523-525.
[43]
Zgoda, J.R.; Porter, J.R. Aconvenient microdilution method for screening natural products against bacteria and fungi. Pharm. Biol., 2001, 39, 221-225.
